[By NBC-1TV H. J Yook]Technolas Perfect Vision GmbH (TPV), a laser company at the forefront of providing advanced ophthalmic laser treatments for presbyopia and cataract surgery, today announced its latest laser treatment for presbyopia, SUPRACOR™, has received CE mark approval and is now commercially available.

SUPRACOR is a LASIK based procedure which is performed on the TECHNOLAS 217P Excimer laser. The procedure can treat a wide range of presbyopic patients, and may also be suitable for patients who have previously undergone a LASIK procedure. The procedure provides excellent distance, intermediate and near vision, whilst maintaining a high quality of vision.

In a multicentre European clinical evaluation performed by Dr. Jean-Jacques Chaubard, Dr. Jorge Castanera, Dr. Dominique Pietrini and Dr. Antoine Roure, the SUPRACOR procedure was found to provide a significant improvement in uncorrected near vision whilst maintaining good distance vision, with a high level of patient satisfaction. The Principal Investigator, Dr. Jean-Jacques Chaubard, from Nice, said, “SUPRACOR is the biggest step in Presbyopia LASIK development in the past 8 years.”

Dr. Kristian Hohla, CEO of Technolas Perfect Vision, commented, “The availability of SUPRACOR, in addition to our minimally invasive intrastromal INTRACOR procedure, allows TPV to provide surgeons with a complete portfolio of laser solutions for presbyopia, meeting the needs of the growing presbyopic patient population.”